Patient versus proxy response on global health scales: no meaningful DIFference.

Brittany R LapinNicolas R ThompsonAndrew SchusterIrene L Katzan

Published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2019)

Our findings revealed the overestimation of symptoms by proxies is a real difference and not the result of measurement non-invariance. PROMIS GH items do not perform differently or have spuriously inflated severity estimates when administered to proxies instead of patients.

Keyphrases

global health
end stage renal disease
public health
prognostic factors
sleep quality